Obstetric Comorbidity Index in Postpartum Hemorrhage

Status Not yet recruiting

Clinical Trial Summary

The objective of this study is to examine the predictive capability of the Obstetric comorbidity index in the identification of severe maternal morbidity associated with postpartum hemorrhage in patients undergoing cesarean delivery.

Clinical Trial Description

The prospectively predictive maternal morbidity is imperative to enhance maternal outcomes. There has been development of the obstetric comorbidity index (OBCMI) by Bateman et al. in 2013 and performed with superior performance characteristics relative to general comorbidity measures in an obstetric population. The score has been a growing recognition of the necessity for specialized risk assessment tools tailored specifically to obstetric populations that differ from other populations. For instance, both the Charlson/Romano comorbidity index or the Elixhauser comorbidity score and their adaptations are deficient in accounting for obstetric conditions, thereby limiting their ability to predict obstetric morbidity or mortality. The Obstetric Comorbidity Index has undergone thorough examination and validation across multiple nations. These findings collectively demonstrate the index's capacity for moderate to high predictive accuracy in anticipating maternal morbidities, accompanied by a commendable discriminative performance. However, within the context of Thailand, investigations concerning the Obstetric Comorbidity Index and its association with perioperative complications or morbidities in postpartum hemorrhage patients undergoing cesarean delivery remain unexplored. Therefore, this study aims to elucidate the correlation between the Obstetric Comorbidity Index and severe maternal morbidity, while also scrutinizing the prevalence of comorbidities during the perioperative period among patients undergoing cesarean delivery at the largest University hospital, in THAILAND. Predicting the rate of maternal morbidity would be advantageous for facilitating preparation and augmenting awareness of complications during the perioperative period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06431204
Study type	Observational
Source	Mahidol University
Contact	Patchareya Nivatpumin, M.D.
Phone	+66896662187
Email	patchareya.niv@gmail.com
Status	Not yet recruiting
Phase
Start date	May 20, 2024
Completion date	April 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04377984` - Impact of a Strategy Combining Morphine Savings and Anesthesia Technique on the Quality of Post-operative Rehabilitation
Recruiting	`NCT03248817` - Phenylephrine Infusion in Cesarean Delivery	Phase 4
Completed	`NCT05037383` - Motion and Viewing Analysis of Surgeons During Minimally Invasive Gynecological Interventions	N/A
Completed	`NCT05933993` - Mothers Experience of Pain Following Elective Cesarean Section. A Qualitative Study.
Recruiting	`NCT05021315` - Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection	Phase 3
Terminated	`NCT03246919` - Ideal Time of Oxytocin Infusion During Cesarean Section	Phase 4
Completed	`NCT06403215` - Effect of Chewing Gum and Drinking Fennel Tea	N/A
Not yet recruiting	`NCT06446258` - Assessment of the Impact of Soft Tissue Mobilization on the Scar in Patients After Cesarean Section	N/A
Recruiting	`NCT06247852` - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Not yet recruiting	`NCT06017076` - Effect of Preoperative Oral Energy Drinks Compared to Warming Matress on Body Temperature During Combined Spinal-epidural Anesthesia for Elective Cesarean Delivery.	N/A
Completed	`NCT05005871` - Comparison of Quadratus Lumborum Intramuscular and Transmuscular in Postoperative Pain	N/A
Recruiting	`NCT04518176` - Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins	N/A
Not yet recruiting	`NCT04505644` - Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section	N/A
Not yet recruiting	`NCT03985618` - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity	N/A
Completed	`NCT04046510` - Comparaison of 3 Protocols of Ocytocin Administration in C Section	N/A
Completed	`NCT03302039` - Three Protocols for Phenylephrine Administration in Cesarean Delivery	Phase 4
Completed	`NCT03318536` - Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section
Recruiting	`NCT03682510` - B-Lynch Transverse Compression Suture Versus a Sandwich Technique (N&H Technique) for Complete Placenta Previa	N/A
Recruiting	`NCT03651076` - Traxi Panniculus Retractor for Cesarean Delivery	N/A
Not yet recruiting	`NCT06060327` - Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.